A Message from Deal Maker This company, known for its autonomous robotic surgical systems, completed a crowd-funded public offering and NASDAQ Listing last year. What’s next? They just filed for FDA approval to market and commercialize their patented AI joint replacement tech. By the year 2027, 50% of knee replacement surgeries will be robotic – up from 12% today. Now they’ve opened a unique opportunity for investors – but it won’t last long. Through Thursday, they are selling preferred shares in their company. This isn’t the same stock trading on the Nasdaq. These unlisted shares pay an 8% dividend yield (in cash or kind) every year. When Warren Buffett invested $10b in Occidental Petroleum, he didn’t buy the publicly traded stock. He got preferred stock paying an 8% dividend. While you won’t be investing alongside Warren Buffett, they are currently offering: - Dividends: The unlisted preferred shares pay an 8% annual dividend (in cash or kind)
- Liquidation Preference: Preferred shareholders are entitled to earlier payment than common shareholders
- Conversion: Preferred shares can be converted 1:1 into common shares
- Redemption: They can buy back preferred shares at a premium
- Warrants: Each preferred share comes with one warrant for future shares of common stock at a fixed price
Public shares closed as high as $3.44 within the past month, but the unlisted preferred stock (which is convertible into one share of common) is available for $2.25 per share. This company currently plans to end the Series D Preferred offering on September 12, 2024. Learn more on their website while the opportunity lasts. | 
0 Response to "Preferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stock"
Post a Comment